Clinical trials: open to volunteers, sponsored by Arrowhead Pharmaceuticals
- Lead sponsor (exact) Arrowhead Pharmaceuticals
- Status Open to volunteers
- Accepts healthy volunteers yes
Alzheimer Disease, Alzheimer Disease, Early Onset
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of ARO-MAPT-SC compared to placebo in adult healthy volunteers and in participants with early Alzheimer's disease (AD), defined as mild…
- Trial name
- NCT07221344
- Testing
- ARO-MAPT-SC
- Where
- 4 sites in Canada, New Zealand
- Volunteers
- 112 people, healthy volunteers welcome
- Sponsor
- Arrowhead Pharmaceuticals
Age-related Macular Degeneration
A First-In-Human Study of ARO-033 in Adult Participants
This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple doses of ARO-033 compared to placebo in adult normal healthy volunteers (NHVs) and the safety…
- Trial name
- NCT07662096
- Testing
- ARO-033
- Where
- New Zealand
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Arrowhead Pharmaceuticals